Skip to main content
. 2017 Jul 4;8(45):78379–78396. doi: 10.18632/oncotarget.18987

Figure 3. Altered protein levels of Akt, Beclin-1, and cyclin D1 of OECM1 and SAS cells treated with HCD.

Figure 3

OECM1 and SAS cells were treated with 1, 5, and 10 μM of HCD for 24 h. Cells were lysed in RIPA buffer for Western blot. Quantization of the expressions of (A and B) Akt, (C and D) Beclin-1, and (E and F) cyclin D1 protein levels were performed, respectively. The results were presented as the mean ± SE of three independent experiments. *P < 0.05 and ** P < 0.01 when compared with the untreated control (0 μM).